{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:48:24Z","timestamp":1778003304562,"version":"3.51.4"},"reference-count":56,"publisher":"Tech Science Press","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.064331","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:45:31Z","timestamp":1751431531000},"page":"2463-2489","source":"Crossref","is-referenced-by-count":1,"title":["Integrating Spatial Multi-Omics and Machine Learning to Unravel the Role of PANoptosis in Bladder Cancer Prognosis and Immunotherapy Response"],"prefix":"10.32604","volume":"33","author":[{"given":"Liangju","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/biomedicines13010086","article-title":"Advances in therapy for urothelial and non-urothelial subtype histologies of advanced bladder cancer: from etiology to current development","volume":"13","author":"Kwon","year":"2025","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 world health organization classification of tumors of the urinary system and male genital organs\u2014part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","article-title":"Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial","volume":"391","author":"Powles","year":"2018","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s44178-023-00057-6","article-title":"Recent highlights of cancer immunotherapy","volume":"2","author":"Fan","year":"2023","journal-title":"Holist Integr Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat Chem Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","article-title":"Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"10","author":"Christgen","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.molcel.2023.07.005","article-title":"NLRP12 senses heme and PAMPs to drive necrotic cell death and inflammation","volume":"83","author":"Bernard","year":"2023","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mib.2020.07.012","article-title":"PANoptosis in microbial infection","volume":"59","author":"Place","year":"2021","journal-title":"Curr Opin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"115696","DOI":"10.1016\/j.biopha.2023.115696","article-title":"The emerging role of PANoptosis in cancer treatment","volume":"168","author":"Xiong","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","article-title":"Advances in mechanism and regulation of PANoptosis: prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"955355","DOI":"10.3389\/fgene.2022.955355","article-title":"PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12967-022-03641-y","article-title":"CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2\/M phase transition, and PANoptosis","volume":"20","author":"Ren","year":"2022","journal-title":"J Transl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","article-title":"Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1323199","DOI":"10.3389\/fimmu.2024.1323199","article-title":"Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1038\/s41598-024-60441-8","article-title":"Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12885-024-12067-2","article-title":"Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.5306","article-title":"Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches","volume":"249","author":"Song","year":"2019","journal-title":"J Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11427-020-1768-y","article-title":"Current status and future perspectives of immunotherapy in bladder cancer treatment","volume":"64","author":"Wu","year":"2021","journal-title":"Sci China Life Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","article-title":"Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtn.2023.07.010","article-title":"Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy","volume":"33","author":"Yi","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-021-25103-7","article-title":"An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer","volume":"12","author":"Gouin","year":"2021","journal-title":"Nat Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1002\/ctm2.1552","article-title":"Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: implications for prognosis and therapy prediction","volume":"14","author":"Ge","year":"2024","journal-title":"Clin Transl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1002\/ctm2.601","article-title":"Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies","volume":"11","author":"Lu","year":"2021","journal-title":"Clin Transl Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"771210","DOI":"10.3389\/fimmu.2021.771210","article-title":"Targeting the CCL2\/CCR2 axis in cancer immunotherapy: one stone, three birds?","volume":"12","author":"Fei","year":"2021","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun Signal"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-017-0848-z","article-title":"An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper\u00ae","volume":"19","author":"Varga","year":"2017","journal-title":"Breast Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12964-018-0266-6","article-title":"Regulation of the master regulator FOXM1 in cancer","volume":"16","author":"Liao","year":"2018","journal-title":"Cell Commun Signal"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.18632\/aging.205242","article-title":"Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma","volume":"15","author":"Qiu","year":"2023","journal-title":"Aging"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7150\/thno.91814","article-title":"Current evidence and therapeutic implication of PANoptosis in cancer","volume":"14","author":"Ocansey","year":"2024","journal-title":"Theranostics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cdd.2014.216","article-title":"Old, new and emerging functions of caspases","volume":"22","author":"Shalini","year":"2015","journal-title":"Cell Death Differ"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"a006080","DOI":"10.1101\/cshperspect.a006080","article-title":"Cell death signaling","volume":"7","author":"Green","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-024-03089-6","article-title":"Cell death shapes cancer immunity: spotlighting PANoptosis","volume":"43","author":"Gao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41598-023-30934-z","article-title":"A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer","volume":"13","author":"Zhuang","year":"2023","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"ref52","first-page":"1","article-title":"A novel defined PANoptosis-related miRNA signature for predicting the prognosis and immune characteristics in clear cell renal cell carcinoma: a miRNA signature for the prognosis of ccRCC","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-030-02601-1_2","article-title":"The NG2 proteoglycan in pericyte biology","volume":"1109","author":"Stallcup","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2990.2002.00412.x","article-title":"The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours","volume":"28","author":"Chekenya","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e23062","DOI":"10.1371\/journal.pone.0023062","article-title":"Targeting the NG2\/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-9\/OncolRes-33-09-64331\/OncolRes-33-64331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:11:56Z","timestamp":1763345516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n9\/63628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.064331","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}